Another study found that CML cells could effectively inhibit the cytotoxicity of baseline and IL-2-induced NK cells to K562 cells through reducing NADPH oxidase-mediated formation of ROS (184) revealing the complexity of interrelation between CML and NK cells. Here, FMO5 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.